
Clindamycin
Severe Skin and Soft Tissue Infections
150 · 300mg
Clindamycin 150 mg and 300 mg, a lincosamide antibiotic for serious skin, soft tissue and dental infections.
Clindamycin, often marketed as Dalacin, is an antibiotic medication chosen to manage various susceptible bacterial infections. It functions by inhibiting bacterial protein synthesis, effectively stalling the spread of harmful microorganisms within the body. This page lists the single available oral capsule formulation, guiding patients toward a better understanding of its application.

Severe Skin and Soft Tissue Infections
150 · 300mg
Clindamycin 150 mg and 300 mg, a lincosamide antibiotic for serious skin, soft tissue and dental infections.
Clindamycin acts as a lincosamide antibiotic. Unlike some treatments that merely slow bacterial activity, this compound works to prevent bacteria from producing the essential proteins required for their growth and replication. Having this oral formulation available provides a targeted option for addressing persistent infections when indicated by a medical evaluation.
Primary uses for this medication include the treatment of a Bacterial Infection. It is frequently considered for Severe Skin and Soft Tissue Infections where other therapies may not be suitable. Physicians may also prescribe this antibiotic to manage a Dental Abscess when specific bacterial strains are the identified cause of the complication.
Recognised brands for this medication include Dalacin and Cleocin. These products are available as a Capsule, hard, providing a consistent way to administer the medication orally. This antibiotic is part of the Antibiotics category, which encompasses a wide variety of medications designed to combat microorganisms.
Standard clinical assessment involves reviewing any history of gastrointestinal conditions, particularly colitis, or known hypersensitivity to lincosamide antibiotics. Laboratory monitoring may be advised depending on the duration of use.
Common responses can involve mild gastrointestinal distress, such as nausea or abdominal pain, which may resolve as the body adjusts. Unusual or persistent digestive symptoms should be reported promptly to a provider.
Other medications, including neuromuscular blocking agents or certain dietary supplements, might alter how this antibiotic performs. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.
Last updated